BioLife & Takeda
Two brands. One parent company. One Art Director — holding two completely opposed visual systems in parallel, every cycle, with zero crossover.
The hardest part wasn't designing for two brands. It was making sure they never looked like
the same one.
BioLife and Takeda are owned by the same parent company but operate as intentionally distinct brands — each with their own visual identity, brand voice, audience, and positioning. Both needed sustained recruitment marketing creative programs running simultaneously. The challenge wasn't producing at volume. It was holding two completely different brand languages in your head at the same time and never letting one bleed into the other.
In a regulated pharmaceutical environment, where every deliverable goes through compliance and legal review before going anywhere, the pressure to default to safe, interchangeable creative is real. The work on both accounts had to resist that pull — staying distinctly BioLife on one account and distinctly Takeda on the other, every cycle, without exception.
BioLife Plasma Services is a consumer-facing plasma donation brand — warm, accessible, community-oriented, designed to speak to everyday donors and healthcare workers in their communities. Takeda is one of the world's leading biopharmaceutical companies, operating in 80+ countries, certified Global Top Employer and Great Place to Work in 25 countries. Same corporate umbrella. Entirely different audiences, entirely different brand voices, entirely different creative problems.
Two brands. Same parent.
Different DNA.
I was the Art Director on both BioLife and Takeda — primary creative on each account under CD direction, owning all art direction decisions and execution independently across both brands simultaneously. During high-volume periods I directed additional designers and offshore resources to maintain output across both accounts without letting either brand's standard drop. The organizational discipline required to run two pharma accounts with opposing brand personalities — inside a compliance environment that reviews everything — is the defining skill this engagement demonstrates.
Every discipline produced twice — once for BioLife, once for Takeda — every cycle, without crossover. The table reads as the engagement's defining structure: identical scope, opposed brand execution.
The hardest part wasn't designing for two brands.
It was finishing the engagement without ever blurring them.
Managing two brands under the same corporate umbrella that intentionally maintain separate identities requires a specific kind of creative discipline — resisting the pull toward visual consistency and instead holding two distinct brand languages simultaneously. Delivered sustained, brand-accurate recruitment marketing creative across both BioLife and Takeda across every format and every production cycle, maintaining visual system integrity and brand voice distinction between a consumer-facing plasma services brand and a global enterprise pharmaceutical company. That's not execution. That's brand stewardship.